biologic

avance nerve graft

acellular nerve allograft-arwx

Loss of exclusivityDecember 2037projected — 12-year biologic exclusivity estimate
CompanyAxogen Corporation

Drug detail

Brand nameavance nerve graft
Active ingredientacellular nerve allograft-arwx
Strength1 LENGTHS: 15 MM, 30 MM, 50 MM, AND 70 MM DIAMETERS: 1 TO 2 MM, 2 TO 3 MM, 3
Dosage formImplant
RouteImplantation
ModalityBiologic
FDA approvalDecember 2025
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

avance nerve graft patent cliff — loss of exclusivity December 2037 | CliffBio